Poster Session II - ACUTE ISCHEMIC STROKE MANAGEMENT 01.00 - ACUTE ISCHEMIC STROKE MANAGEMENT - 01.03 - HYPERACUTE MANAGEMENT P667 - ESOC25-2238 DIAGNOSTIC ACCURACY OF POINT-OF-CARE VISCOELASTIC ASSESSMENT OF DIRECT ORAL ANTICOAGULATION IN ACUTE ISCHEMIC STROKE: INTERIM RESULTS FROM A PROSPECTIVE VALIDATION STUDY Annahita Sedghi 1 , Eva Meyer-Bender 1 , Lars Heubner 2 , Joerg Pietsch 3 , Oliver Tiebel 4 , Kristian Barlinn 1 , Jan Beyer-Westendorf 5 , Volker Puetz 1 , Peter Spieth 2 , Timo Siepmann 1 1 Dresden Neurovascular Center, Department of Neurology, Medical Faculty and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany, 2 Department of Anesthesiology and Intensive Care Medicine, Medical Faculty and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany, 3 Institute of Legal Medicine, Medical Faculty and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany, 4 Institute of Clinical Chemistry, Medical Faculty and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany, 5 Thrombosis Research Unit, Department of Medicine I, Medical Faculty and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany Background and Aims: Intravenous thrombolysis in patients with acute ischemic stroke (AIS) is often delayed because of uncertainty about the presence of direct oral anticoagulants (DOACs)
Therefore, it is of utmost importance to investigate future potential treatments in adequately designed preclinical and clinical trials
Not only that, but all individuals in every life stage can engage in strength training routinely to stay mobile and capable of everyday activities and to prevent falls and fractures
Tau: From research to clinical development
Our IGF-1 LR3 Peptide is stored and handled according to industry guidelines to ensure stability
